when bruschi suffered a stroke in 2005, he was treated at massachusetts general hospital, which he said was well equipped to handle the medical emergency. .
biohaven: "rimegepant pivotal phase 3 trial results -- conference call." .
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .
OFF DEAL
OFF DEAL
OFF DEAL